CVE-2010-4513

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in Zimplit CMS 3.0, and possibly earlier, allow remote attackers to inject arbitrary web script or HTML via the (1) file parameter in a load action to zimplit.php and (2) client parameter to English_manual_version_2.php.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 1.08% Top 25%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.htbridge.ch/advisory/xss_vulnerability_in_zimplit_cms_1.html exploit
http://www.htbridge.ch/advisory/xss_vulnerability_in_zimplit_cms.html exploit
http://www.securityfocus.com/bid/45252 vdb entry exploit
http://packetstormsecurity.org/files/view/96466/zimplit-xss.txt exploit
http://www.securityfocus.com/archive/1/515078/100/0/threaded mailing list
http://marc.info/?l=bugtraq&m=129182251500541&w=2 mailing list exploit
http://secunia.com/advisories/41629 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2010-4513?
CVE-2010-4513 has been scored as a medium severity vulnerability.
How to fix CVE-2010-4513?
To fix CVE-2010-4513, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-4513 being actively exploited in the wild?
It is possible that CVE-2010-4513 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.